Fearless Innovation, Boundless Vision: Seventh Future Healthcare 100 Summit 2023 Unveils Agenda Highlights and Ecosystem Products
Over the past decade, the global healthcare industry has undergone significant restructuring, a transformation accelerated by the COVID-19 pandemic since 2020. Having withstood the compounded challenges of global upheaval and the century-defining pandemic from 2020 to 2022, 2023 marked the first year for implementing the strategic arrangements of the 20th National Congress of the Communist Party of China and a critical year for advancing the 14th Five-Year Plan. Only by accumulating strength, demonstrating the resilience to “stand firm despite countless trials and tribulations,” embodying the spirit to “forge ahead amid greater difficulties,” and reinforcing confidence through decisive action can innovators in the healthcare sector successfully deliver on the era’s mandate for high-quality development in healthcare.
"Do what you do, and ask not of west or east."
In 2023, the 7th Future Healthcare Top 100 Conference, themed “No Boundaries,” will be grandly held at the Zhangjiang Science Hall in Shanghai from May 5 to 7, 2023. The event is organized by VB100, VCBeat, and Eggshell Research Institute, with strategic cooperative support from Shanghai Zhangjiang Group.
As the largest and most information-rich ecosystem conference integrating industry and capital in China’s medical and health innovation sector, the event centers on “connecting global wisdom, sharing cutting-edge technologies, inspiring the future of tech, and fostering venture capital interaction,” thereby setting the direction for innovation and investment in China’s healthcare field. The 7th Future Healthcare 100 Conference (2023) will bring together a diverse array of guests and attendees, including government agencies, academicians and scientists, research and clinical experts, Fortune 500/listed companies, top-tier investment institutions and securities firms, and innovative healthcare enterprises. Through this gathering of minds, the conference aims to provide insights to the industry and usher in a new future.
Gathering of Industry Leaders from Government, Academia, Research, Industry, Investment, and Finance
Led by Academicians and IEEE Fellows, nearly 300 industry luminaries present the most cutting-edge medical technologies, industry trends, and business innovations;
6 Major Rankings, 3 Awards Announced
Top 100 Innovative Medical Devices, Top 100 Innovative Biopharmaceuticals, Top 100 Innovative Healthcare Services, Top 100 Innovative Digital Health, Top 100 Innovative Healthcare Commerce and Supply Chain Services, Top 100 Innovative Overseas Healthcare; the Weilan Awards, Pengcheng Awards, and Value Sector Awards were simultaneously released; gathering the core forces of future healthcare, with 1,000+ unicorns and high-potential innovative enterprises jointly exploring the path of innovative development;
Release of 1+N Industry Research Reports
Growth Analysis Report on the Top 100 Future Healthcare Enterprises: Defining the Growth of Core Forces in Future Healthcare; Premier Release of 10+ Industry Research Series Reports, Covering Genetic Testing, Digital Pharmaceutical Marketing, Health Insurance, Organoids, Radiopharmaceuticals, Energy-Based Aesthetic Devices, and More, to Explore Development Opportunities and Innovative Cases in Niche Sectors;
10+ Enterprises/Institutions Co-Creating an Industrial Innovation Ecosystem
The Future Healthcare Top 100 Conference has established in-depth collaborations with Proxima Ventures, Boyuan Capital, CDH VGC, Fumilei, Fusote, GTJA Investment, Hetang Venture Capital, Huagai Capital, Huakong Fund, China Renaissance, Jinding Capital, Matrix Partners China, Legend Capital, Qiming Venture Partners, Weilai Capital, 5Y Capital, Industrial Securities Economic and Financial Research Institute, Yinyue Medical Fund, and Yunqueyi (listed in alphabetical order, not in order of priority) to jointly create an innovative ecosystem for the healthcare industry;
4 Formats, 7 Concurrent Events: Close-Range VC Exchange
Concurrent events at the conference venue will include the Top 100 Gala, Global Innovation Project Pitching/Research Achievement Commercialization Pitching, Corporate/Product Promotion Sessions, Closed-Door Seminars, Ecosystem Conference, Innovation and Entrepreneurship Enterprise Exhibition, and Matchmaking & Negotiation Zone, aiming to build a communication and matchmaking platform for the entire healthcare industry chain and efficiently link all key resources across industry, academia, research, and investment.
(The following is a tentative schedule; specific forums and topics are subject to on-site arrangements.)
Summit Theme——Stay true to your original aspiration, dare to be courageous, and ask not of west or east
1. Paying tribute to innovators, sharing stories of top scientists tackling world-class medical challenges around the theme of “Conquering the Impossible”;
2. Wang Yutian, Fellow of the Royal Society of Canada and Dean of the School of Life and Health Sciences at Shenzhen University of Advanced Technology (under preparation), has confirmed his attendance;
3. Top investors jointly explore innovative hotspots that are reshaping the future trajectory of global healthcare development;
4. Roundtable with Leading Experts in Research and Business: Sharing Optimal Solutions for Med-Engineering Interdisciplinary Collaboration and Technology Transfer;
Salute to the Future
▸Rebreathing
▸Future Healthcare Hub Cities: Innovation Ecosystems, Thriving Growth
Paradigm Concept
▸Pharmaceutical Innovation and Transformation: How Technological Innovation, Regulatory Reform, and Global Collaboration Will Drive Innovation
Conquering the Impossible
▸Programming Life—Gene Therapy and Gene Editing
▸Decoding Life: The Latest Advances in Synthetic Biology
▸AI+: Redefining Drug Discovery
▸Making Regeneration Possible
▸Brain-Computer Interfaces and Neuromodulation
▸Center Stage of the Era: Seeking the Optimal Solution for Med-Engineering Convergence and Technology Transfer
Foreseeing the Future
▸The Wave of New Drugs Going Global Amidst the Restructuring of the Global Supply Chain
▸"The 'Chinese Core' of the Upstream Life Sciences Supply Chain"
▸“Healthcare + Deep Tech”: Where Lies the Paradigm of Disruptive Innovation in Life Sciences?
▸Global New Drug R&D under Collaborative Innovation
▸Scientists × Entrepreneurs: From the Laboratory to Industrialization
▸New Healthcare Infrastructure: Accessibility, Affordability, and Sharing of Healthcare Services
Summit Theme——Business Leaders Chart the Future Path of Healthcare in Their Vision
1. Industrial Securities Economic and Financial Research Institute, as a co-organizer, jointly hosted this summit;
2. 10+ leading enterprises to deliver speeches, sharing industry trends and corporate strategic plans;
3. Comprehensive Sector Coverage: Covering listed industry leaders in pharmaceuticals, CROs, IVD, vaccines, healthcare services, digital health, and commercial distribution, to explore the development pathways of China’s innovative forces and the forefront of medical technology concepts;
"If There Is Light"
▸Global Economic Outlook
▸Innovation Trends and Opportunities in Future Healthcare
VBInsight
▸Commercial Insights from Leading Publicly Listed Companies
Pale Blue Dot
▸In the Wave of Globalization: Future Medical Technology Innovation and Value Investment
Summit Theme——Discovering the Core Power of Future Healthcare
1. Witnessing industrial innovation and practice amid the evolution of innovative technologies, and exploring collaboration and ecosystems among stakeholders across the industry chain, as well as between government, industry, academia, and research institutions;
2. Gain insights into the annual summaries and future innovation roadmaps of industry-leading enterprises, as well as their enterprise-level ecosystem strategies spanning channels, commerce, capital, and marketing;
Boundless Imagination
▸Disruptive Innovations in Hard-Tech Healthcare: CGT, Nucleic Acid Therapeutics, Brain Science, and More
▸The Rise of Pharmaceutical and Medical Device CROs/CDMOs
The Path to the Top 100
▸The Game-Changer and Innovator in Upstream Raw Materials
▸New Entry Points for the High-Quality Development of the Silver Economy
Value Reshaping
▸How Can Medical Services Such as Dentistry, Ophthalmology, Rehabilitation, and Aesthetic Medicine Innovate Their Systems?
▸Digital Empowerment: Building a New Ecosystem for Smart Healthcare
Innovation Landscape
▸Collaboration and Ecosystem among Government, Industry, Academia, and Research
▸Industrial Clusters Empower a New Industrial Ecosystem
1. Huakong Fund and Jinding Capital, as supporting organizations for the forum, are helping to build this summit. The summit will provide healthcare GPs and LPs with opportunities for in-depth face-to-face exchanges. More than 20 top investment guests have confirmed their attendance, gathering core industry forces to jointly promote innovation and transformation in the healthcare industry;
2. Centering on core relationships among LPs and GPs, government guidance funds and other fund-of-funds, overseas capital, and large conglomerates, the summit explored the recognition of and response to changes in healthcare investment from three perspectives: global shifts, China’s transformations, and industrial evolution;
3. BGI Win-Win, Huakong Fund, Hengxu Capital, Ding Capital, and Panlin Capital have confirmed their attendance at the forum;
Hot Topics
▸Building a New Industry-Finance Ecosystem for Synergistic Development of “Funds, Platforms, Projects, and Talent”
▸Leverage the Advantages of Fund-of-Funds to Build an Integrated Service Chain for the Greater Health Industry
▸White Horse or Dark Horse: The True Angel Scouts Behind Investment Institutions
▸Winter Clears the Bubble, Sustained Investment in the Bioeconomy Industry
▸Rational Reflections Amid the “Investment Fever” in Cell and Gene Therapy
▸New Logic Amidst the Changing Investment Landscape
▸Post-Pandemic Era: Directions for Global Healthcare Innovation and Investment Trends
▸Venture Capital Going Global: North America vs. Southeast Asia
▸Echoes and Future Symphony of Healthcare Investment in China’s Primary Market
▸New Venture Capital, New Outlook: A Discussion on Post-Investment Management in Healthcare
▸From the Industry, For the Industry
▸Where Will China’s Healthcare Industry Innovation Focus in the Next Decade?
Forum on the Translation Platform for Innovative Drug Research Achievements
1. Legend Capital, as a co-organizer of the forum, jointly hosted this event, facilitating in-depth discussions on two key themes: platform development for early-stage R&D in innovative drug translation, and platform development for the clinical translation phase;
Hot Topics
▸ Integrated Supply of Instruments and Reagents for the Early R&D Phase
▸ Development of Animal Models to Empower Early-Stage Translation
▸ Preclinical Capability Building and Translational Bridging
▸ Efficient GMP translation capabilities supporting IITs and INDs
Personalized Diagnosis and Treatment Forum
1. ChenAn Bio, Jinxiang Medicine, Jingzhi Future, Kuoran Biotech, and Zhiben Medical have confirmed their attendance at the forum;
Hot Topics
▸Interpretation of Policies Related to Precision Diagnosis and Treatment
▸Applications of Single-Cell Technologies in Drug Development and Clinical Testing Markets
▸How Miniaturization of Mass Spectrometry Breaks the Boundaries of Analytical Testing and Facilitates Clinical Applications
▸Discovery of Novel Biomarkers Expands the Application Space of Precision Oncology
▸Multiplex Fluorescence Immunohistochemistry: Best Practices for Next-Generation Molecular Pathology Applications
▸Accelerating the Clinical Application of Breath Testing Through Next-Generation Exhaled VOC Analysis Technology
▸How Can Companies Achieve Breakthroughs in Technological and Product Differentiation Amid a Capital Winter?
▸Leaving Behind the Era of Disorderly Expansion: How Can Personalized Oncology Diagnosis and Treatment Embark on a New Chapter for the Industry?
Forum on Innovative Development of Photoelectric Medical Aesthetics & Release of the White Paper on Energy-Based Devices in Medical Aesthetics
1. Fumilei, as a co-organizer of the forum, jointly creates this event to explore future innovation possibilities in China's optoelectronic medical aesthetics industry;
2. VCBeat Releases "White Paper on Energy-Based Devices in Medical Aesthetics";
3. Li Changhui, Distinguished Researcher at the Department of Biomedical Engineering, Peking University, has confirmed his attendance at the forum;
4. Minovis, Yimu Vision, and Yuanyi Capital have confirmed their attendance at the forum;
Hot Topics
▸New Momentum for the “Dual-Beauty Integration” Driven by the Appearance Economy
▸How to Leverage Innovative Technologies to Navigate the Major Transformation in the Medical Aesthetics Industry?
▸Development Opportunities for Drug-Combined Photoelectric Therapy in Dermatology
▸Applications of Visualization Technology in the Medical Aesthetics Industry
▸Tackling Differentiated Overseas Markets and Strengthening Presence in China to Win Together in the “Golden Age” of Aesthetic Lasers
▸Exploration of Corporate Innovation and Upgrade Paths Amidst the Transformation of the Medical Aesthetics Industry
▸Challenges and Opportunities for Chinese-Made Photoelectric Medical Aesthetics Devices Amid the Trend of Domestic Substitution
Forum on Innovative Development of the Synthetic Biology Industry
1. With all the essential elements for development in place, how will synthetic biology respond to the expectations of our time? The forum launched cutting-edge discussions through two thematic sections: "Synthesis for Knowledge" and "Creation for Application."
2. Hengxu Capital and Yixi Biology have confirmed their attendance at the forum;
Hot Topics
▸Frontier Advances and Technical Applications of Synthetic Biology in the Field of Life and Health
▸From the Lab to the Production Line: How to Cross the “Valley of Death” in Synthetic Biology Industrialization?
▸Synthetic Biology in the Spotlight: What to Invest In and How?
▸Breakthroughs in Foundational Technologies: How to Build a Standardized Platform for Synthetic Biology?
▸Crafting Beauty: Synthetic Biology Unlocks New Horizons in Medical Aesthetics
▸How Synthetic Biology Is Disrupting Innovation in Pharmaceutical R&D?
▸Exploring New Forms of Life Through Research and Imagination
▸The Innovation Landscape of Synthetic Biology Amid Technological Leaps
Radiopharmaceuticals Forum: A New Cycle of Innovation in Radiopharmaceuticals
1. VCBeat Releases "Research Report on the Radiopharmaceutical Industry";
2. Grand Pharma confirms its attendance at the forum;
Hot Topics
▸Progress of the Radiopharmaceutical Industry from Macro Perspectives: Regulation, Investment and Financing, and Industrial Landscape
▸The Path to Clinical Implementation of Innovative Radiopharmaceuticals in China
▸From Easy to Difficult: The Innovation Path of a Pioneer in China’s Nuclear Medicine Industry
▸Breakthrough Directions for New Entrants in the Radiopharmaceutical Sector
▸Strategies for Addressing Gaps in the Upstream Segment of the Industry Chain
▸Where Does Source Innovation in Radiopharmaceuticals Come From?
Forum on the Innovative Development of Internet Hospitals and Smart Hospitals
1. Invite multiple renowned hospitals and industry-leading enterprises to jointly explore hot trends and innovative integration across the entire process of the industry-academia-research-application ecosystem, from in-hospital to out-of-hospital settings;
2. NetRain has confirmed its attendance at the forum;
Hot Topics
▸How Should Internet Hospitals Initiate Practices for Improving Medical Quality?
▸Reflections on the Path to Lean Management in Public Hospitals
▸How Should Integrated Continuous Managed Care Services Across In-Hospital and Out-of-Hospital Settings Be Implemented?
▸How Digital Technology Supports Medical Quality and Safety in Internet-Based Diagnosis and Treatment Services?
▸How Can Third-Party Technical Support Providers Facilitate Enterprises' Digital Transformation?
▸Advancing the Capacity Building of Clinical Specialty Services to Promote the Improvement of Medical Quality
▸Prospects for Accelerating the Development of Healthcare Informatics in the Era of DRG/DIP Payment
▸“Internet+” Full-Course Disease Management System: Opportunities and Challenges
ITBT & AI Drug Discovery Forum
1. As a supporting organization for the forum, 5Y Capital helped shape this event to jointly drive future industrial breakthroughs in ITBT and AI-driven drug discovery;
2. AliveX Biotech Confirmed to Attend the Forum;
Hot Topics
▸Scientific Computing in Small-Molecule Drug Discovery
▸Paradigm Shift in Biopharmaceuticals: The Era of Biological Macromolecules
▸AI-Driven R&D of Novel Biomarkers and Targets
▸Application of 3D Printing Technology in New Drug Screening
▸The Infinite Possibilities of ITBT and Synthetic Biology
▸High-Performance Computing Solutions for the AI Drug Discovery Industry
▸AI Technology Empowers Drug R&D
▸The Future of ITBT and AI-Driven Drug Discovery
Forum on Innovative Development of Spinal Health & Strategic Cooperation Launch Ceremony for the “National Backbone” Protection Initiative
1. Fusote, as a co-organizer of the forum, jointly creates this event to promote industrial development by focusing on the construction of a national spinal health system and the industrial ecosystem;
2. Witness the launch ceremony of the strategic partnership for the “Backbone of the Nation” Protection Project, joining hands to safeguard spinal health among Chinese adolescents;
3. China Resources Pharmaceutical Commercial Group Medical Device Co., Ltd. and Fusote have confirmed their attendance at the forum;
Hot Topics
▸New Demands and Challenges in Health Management and Education for Contemporary Primary and Secondary School Students
▸Focus on Spinal Health: Supporting Screening, Diagnosis, and Treatment of Adolescent Spinal Conditions
▸“National Pillars” Guardian Project Strategic Cooperation Launch Ceremony
▸The Necessity and Challenges of Building a Screening, Diagnosis, Treatment, Rehabilitation, and Prevention System for Scoliosis
Forum on Health Management and Innovative Development of Health Insurance
1. Yunqueyi, as a co-organizer of the forum, jointly created this event, bringing together numerous experts to engage in dialogue with platform-based and innovative enterprises on industry trends and ecosystem integration;
2. VCBeat Releases "Innovation Report on the Health Insurance Industry";
3. Huiyi Health and Lejian Information have confirmed their attendance at the forum;
Hot Topics
▸How Can Commercial Health Insurance Participate in the Construction of a Multi-Tiered Medical Security System?
▸Building Digital and Intelligent Health Management Across the User's Full Lifecycle
▸Digital Empowerment at the Grassroots Level: How to Meet the Needs for Supplementary and Upgraded Medical Services in Primary Care?
▸“Human-Machine Integration” Brain-Computer Interface Technology Unlocks Greater Possibilities for Health Management
▸Multi-Omics + AI: Upgrading Cancer Early Screening Services
▸New Strategies and Solutions for Breaking Through in the Sleep Health Industry / Lifestyle Medicine Empowering Proactive Health Management
▸How Insurtech Is Leveraging the Trillion-Yuan Elderly Care Market
▸Multi-tiered Payment: Huiminbao and Health Insurance Accelerate Coverage for Non-Standard Risks
▸Building a Closed-Loop Management System for “Pharmaceuticals, Medical Services, Testing, and Insurance”: How Can Health Management and Health Insurance Be Deeply and Organically Integrated?
Frontier Innovation Forum on Interventional Artificial Hearts
1. Focusing on the latest wave of hot topics and technologies surrounding transcatheter artificial hearts, this initiative brings together leading experts, enterprises, and investors to conduct an in-depth analysis of the development prospects, strategic directions, current bottlenecks, and future challenges of transcatheter artificial hearts;
2. Feidun Medical Confirms Attendance at the Forum;
Hot Topics
▸Research and Development Progress and Future Prospects of Minimally Invasive Artificial Hearts
▸ The Final Battlefield: A Multibillion-Yuan Heart Failure Management Market Welcomes New Opportunities
▸ Technical Pathway Selection for Interventional Artificial Hearts
▸ Sharing Experiences on Industry-Academia-Research Collaboration for Interventional Artificial Hearts
▸ Competitive Landscape and Strategic Analysis of Interventional Artificial Hearts in the Heart Failure Market
Forum on Innovative Development of Visual Imaging Equipment
1. As a supporting organization for the forum, Yueyin Medical Fund helps to build this event, jointly exploring the cutting-edge technologies and innovative growth of visual imaging equipment;
2. Liu Shiyuan, Director of the Department of Radiology at Shanghai Changzheng Hospital and Chairman of the Chinese Society of Radiology under the Chinese Medical Association, and Dennis Wilkens, China Representative of Germany Trade & Invest, have confirmed their attendance at the forum;
Hot Topics
▸ Development Direction of the Medical Imaging Equipment Industry Under the Trend of Domestic Substitution
▸ Benchmarking the Surge in Corporate R&D Under the “GPS” Framework
▸ Exploring AI Empowerment to Drive the Upgrading of the Artificial Intelligence Medical Imaging Industry
▸ The Inevitability and Challenges of Integrated Imaging Development
▸ Clinical Challenges and Applications of AI Imaging in Oncologic Imaging
▸ Development Prospects and Outlook for AI-Integrated Imaging Equipment
▸ Development Opportunities for High-End Domestic Medical Imaging Equipment
▸ Technological Innovations and Investment Opportunities in Imaging Equipment
Research Achievement Commercialization Project Roadshow
1. Hetang Venture Capital and ZKCX Star, as supporting organizations, facilitated the project roadshow by bridging early-stage projects with investment institutions, establishing an interactive platform for showcasing projects and fostering collaborative exchanges to promote the commercialization of scientific and technological achievements;
Hot Topics
▸ Exchange of Medical Innovation Experiences among Research Institutes at Home and Abroad
▸ As investment firms delve deeper into early-stage healthcare, how can they support scientists’ growth?
Project Pitch
▸ Showcase of Outstanding Domestic Scientific and Technological Achievements in Translation
Organoid and Organ-on-a-Chip Forum
1. As a supporting organization for the forum, GaoTeJia Investment helped facilitate this event, promoting technical exchanges among companies in the organoid and organ-on-a-chip sectors, and exploring the opportunities and challenges involved in translating research from the laboratory to clinical applications and ultimately to industrialization;
2. VCBeat Releases "Organoid Industry Report";
3. Leading investment firms and innovative enterprises in the fields of organoids and organ-on-a-chip technology convened to share insights on sector hotspots and industrial layouts, jointly mapping out a new vision for industry development;
Hot Topics
▸ Overview of the Development and Opportunities of Organoids and Organs-on-Chips in China
▸ Current Status of Industrialization and Upstream-Downstream Collaboration for Organoids and Organs-on-Chips
▸ Latest Advances in Organ-on-a-Chip and Microphysiological Systems
▸ Regulatory and Compliance Issues for Organoids and Organs-on-Chips
▸ Standardization of Organoid Technology and Application Scenarios
▸ Applications of Organoids and Organs-on-Chips in Drug Development
Forum on Trends in the Brain Science Industry
1. China Renaissance, as a co-organizer of the forum, jointly creates this event to decode the innovation secrets behind the “final frontier” of life sciences;
2. Bositeng, NeuroXess, and Qiongding Medical have confirmed their attendance at the forum;
Hot Topics
▸ Development Trends in Brain Science and Brain-Inspired Intelligence
▸ Amid the Hype, Where Lie the Real Investment Opportunities in Brain Science?
▸ Breakthroughs in foundational brain-computer interface technologies, building end-to-end comprehensive solutions
▸ Brain Science Initiates Innovation in the Field of Neuromodulation
▸ How Brain Science Is Revolutionizing Screening and Intervention for Cognitive Impairment
RNA Therapy Forum
1. Huagai Capital, as a co-organizer of the forum, jointly hosts this event to discuss new chapters in RNA therapeutics and expand the frontiers of the RNA therapy field;
2. Qinglan Biotech and Xinhe Biotech have confirmed their attendance at the forum;
Hot Topics
▸ Advances in RNA-Based Drug Modalities
▸ New Key Points in Preclinical/Clinical Evaluation of Frontier RNA Therapies
▸ The Next Chapter of mRNA Has Begun
▸ Circular RNA is Entering Its Golden Age
▸ Why Could This Year Be a Big Year for Oligonucleotide Therapeutics?
▸ New Breakthroughs in Delivery Challenges, Renewed Hope for RNA Therapies
▸ Fully accelerating the industrialization of cutting-edge RNA therapies
▸ Current Hotspots and Challenges in RNA Therapeutics
Life Science Tools Forum
1. Matrix Partners China, as a co-organizer of the forum, jointly creates this event to empower and accelerate innovative development and collaborative cooperation across the upstream and downstream segments of the industry;
Hot Topics
▸ To Do a Good Job, One Must First Sharpen One’s Tools: A Preliminary Look at the Life Science Tools Industry
▸ Amid the Development of Emerging Therapies: New Challenges and Opportunities for Upstream Tools
▸ The Journey and Prospects of Global Exploration in Life Science Tools
▸ Empowering IVD raw materials to accelerate the localization of the upstream NGS supply chain
▸ Development, Application, and Technological Innovation of High-End Culture Media as Key Upstream Raw Materials
▸ Opportunities and Challenges in the Single-Use Bioreactor Industry
▸ Infrastructure for Life Sciences Research: Laboratory Instruments and Equipment
▸ "How Can Domestic Innovators in Life Science Tools Navigate Toward International Giants Post-Pandemic?"
▸ What are the systemic opportunities for China's biopharmaceutical industry as it reaches the threshold of large-scale industrialization?
Forum on Innovative Development of Surgical Robots
1. CDH VGC, as a supporting organization for the forum, helped facilitate this event by fostering discussions on innovative development and industry growth drivers in sectors such as vascular intervention, orthopedics, and laparoscopic surgical robotics;
2. Tuodao Medical has confirmed its attendance at the forum;
Hot Topics
▸ Discussion on the Clinical Application of Surgical Robots
▸ Differentiation Path for Vascular Interventional Surgical Robots: Full-Process Coverage of Diagnosis and Treatment
▸ From Multi-Port to Single-Port: The Path to Breakthrough for Laparoscopic Surgical Robots
▸ Exploring Comprehensive Solutions for Orthopedic Surgery
▸ Application of Surgical Robots in the Field of Microsurgery
▸ ChatGPT Ignites “AI+”: How AI Empowers the Development of Surgical Robots
▸ The Present and Future of Chinese-Made Surgical Robots
Forum on Innovative Practices in the Digital Therapeutics Industry
1. Liu Chongsheng, Secretary-General of the Digital Therapeutics Professional Committee of the China Association for Medical Devices Industry, has confirmed his attendance at the forum;
2. Botong Medical and Zhilan Health have confirmed their attendance at the forum;
Hot Topics
▸ The Next Stop for Innovative Development in the Digital Therapeutics Industry
▸ In the Era of Digital Therapeutics: How Pharmaceutical and Medical Device Companies Can Go Global and Bring Innovations Home
▸ Creating a Closed Loop from Technology to Product in Digital Therapeutics
▸ Digital Therapeutics Reshape the Industrial Ecosystem of Internet Healthcare
▸ Digital Therapeutics Drive the Digital-Intelligent Transformation of Chronic Disease Management
▸ Digital Therapeutics Revolution: A New Ecosystem in Specialty Disease Areas
▸ Commercial Breakout Strategies for Innovative Companies Amid Homogeneous Competition
▸ The Collision of Technology and Capital: From Scientist to Entrepreneur
Cell and Gene Therapy Forum
1. CDH VGC, as a supporting organization for the forum, contributed to its success by focusing on clinical applications, R&D services, trending sectors, and industrialization processes, thereby exploring the forefront of developmental pathways and technological concepts driving innovative forces;
Hot Topics
▸ Clinical Application Exploration of Cell Therapy Products
▸ New Key Points in the Clinical and Preclinical Evaluation of CGT Products
▸ The New Frontier for Cell Therapy: How Far Are We from Conquering Solid Tumors?
▸ Navigating the Deep Waters of Cell Therapy: iPSC Technology Unveils a New Chapter
▸ Gene Editing Enters the Clinical Lane: How to Balance Safety and Efficacy
▸ Novel Gene Editing Technologies Drive the Next Wave of Source Innovation
▸ Specializing in CGT CDMO: How to Reduce Costs and Improve Efficiency
▸ How to Strategically Position for Source Innovation and Industrialization in CGT?
Frontiers in Vascular Interventional Innovation Forum
1. VCBeat Releases "Structural Heart Disease" Report;
2. Aikemai, Keruichi, and Shengde Medical have confirmed their attendance at the forum;
Hot Topics
▸ Outlook on the Direction of Endovascular Interventional Therapy in the Next Decade
▸ How Does the “Chinese Power” in Globalization/Localization Strategy Transform the Market?
▸ Innovation-Driven Development Engine: Building a Leading Platform for Minimally Invasive Interventional Oncology
▸ “Cardiovascular Devices + AI + Services” Industrialization Platform for Innovative Structural Heart Disease Diagnosis and Treatment Technologies
▸ Reflections on the Wave of Domestic Substitution Initiated by the Upgrade of Electrophysiology PFA Technology
▸ Comprehensive Stroke Solutions, Targeting the Blue Ocean Market in Neurointervention
▸ The Final Battlefield: New Opportunities in the Multi-Billion Yuan Heart Failure Management Market / The Vascular Interventional Robotics Arena Contested by Industry Giants
▸ Challenges and Outlook for the Vascular Intervention Market Amid the Centralized Procurement Storm
Ophthalmology Industry Innovation Forum
1. Boyuan Capital, as a forum supporting organization, and Business Finland, as a forum cooperating partner, jointly facilitate the hosting of this forum to explore innovative trends in ophthalmology and analyze investment value points within the ophthalmic industry;
2. Li Jiaxuan, Head of China for the Healthcare Sector at Business Finland, and Fan Bei, Head of China at iCare, have confirmed their attendance to deliver speeches at the forum;
3. Weivue Imaging confirms attendance at the forum;
Hot Topics
▸ Current Status and Future of Optometry Development in China
▸ Innovative Development of Ophthalmology in China from a Global Perspective
▸ Investment Logic and Opportunities in the Ophthalmology Sector
▸ The Impact of OCTA on Ophthalmic Diagnosis and Treatment and Future Trends
▸ Development and Breakthroughs in Intraocular Lenses
▸ Independent R&D of Novel Drugs (Cell and Gene Therapy/Macular Degeneration)
▸ How Can Domestic Enterprises Break Through the Blockade of Imported Mid-to-High-End Pharmaceuticals and Medical Devices?
Pharmaceutical Enterprise Digital Marketing Forum
1. VCBeat Releases "Digital Marketing for Pharmaceutical Companies";
2. Jingli Technology, MedSci, Qingyun Technology, and Wanmu Health have confirmed their attendance at the forum;
Hot Topics
▸ How can digital-driven pharmaceutical marketing sustain its growth trajectory and expand the out-of-hospital market space?
▸ Patient-Centric Innovation in Digital Marketing for Internet-Plus Chronic Disease Management
▸ AI Empowers Multiple Values: How Can Innovative Models Help Pharmaceutical Companies Conduct Omni-Channel Marketing?
▸ How Can Precision Marketing in the Pharmaceutical Industry Maximize User Value?
▸ Engine-driven patient education: Building an omnichannel, scenario-based content marketing service
▸ Analysis of Transformation Trends in the Digital Pharmaceutical Marketing Industry and Key Enterprise Development Models?
▸ How to Grasp User Needs and Measure the Effectiveness of Digital Marketing?
Forum on Innovative Development in Nutritional Sciences
1. As a co-organizer of the forum, Weilai Capital jointly hosted this event, delivering in-depth thematic insights on topics such as technological innovation and practical applications to empower integrated industrial innovation and strategic thinking;
Hot Topics
▸ Precision Nutrition for Multiple Clinical Conditions / Comprehensive Nutritional Management for Patients Undergoing Colorectal Cancer Resection
▸ No Creation Without Destruction: The Nutrition Science Track
▸ New Advances in Research on the Human Microbiome and Health
▸ Dairy Innovation Practices Addressing Population-Specific Nutritional and Health Needs
▸ Exploring the Health Value and Applications of Phytonutrients
▸ The Role of Complete Nutritional Formulas in the Nutritional Therapy of Cancer Patients
▸ Application of a Low-Purine Balanced Diet in the Management of Hyperuricemia and Gout
▸ Gestational Diabetes Mellitus: A Window for Maternal and Infant Health Management
▸ Innovative Integration and Development in the Nutrition Sector
Forum on Innovative Development in Regenerative Medicine
1. Huiding Capital, as a supporting organization for the forum, helps to build this event, focusing on the core hotspots of regenerative materials and tissue engineering to explore more possibilities for future innovation;
2. Trautec Medical confirms attendance at the forum;
Hot Topics
▸ Latest Research Advances in Tissue Engineering and Regenerative Medicine
▸ The Prospects of Regenerative Aesthetics—Material-Driven Innovation
▸ Product Strategy and Portfolio Planning in the Era of Regeneration
▸ Clinical Applications of Bioprinting in Tissue Repair
▸ R&D Challenges in Tissue Engineering Technology
▸ Market Prospects of Regenerative Medicine from a Capital Perspective
▸ Development Prospects and Commercialization of Regenerative Medicine
Smart Laboratory Forum
1. Focusing on the innovative transformation of China's smart laboratory sector from three dimensions: future laboratories, hardware-software innovation, and value connectivity;
2. Hamzandi confirms attendance at the forum;
Hot Topics
▸ A Market Worth Hundreds of Billions: Laboratories Ignite a New Wave of Smart Construction
▸ Drug Discovery in Smart Laboratories
▸ Smart Laboratory Development Driven by Technological Innovation
▸ “Intelligent Manufacturing in China” for TLA (Total Laboratory Automation)
▸ IoT + Software: Automated Sample Management for Assembly Lines
▸ Digital Transformation of Laboratories: Breaking Down Data Silos
▸ AI + Robotics: A Smart Laboratory
▸ Cold Chain Entry, Intelligent Sample Management
▸ How Far Are We from the “Smart Laboratory” Through Hardware-Software Integration?
Forum on Innovative Development in the Traditional Chinese Medicine Industry
1. Starting from upholding fundamental principles while fostering innovation and driving informatization transformation, this study explores the industrial revitalization, international expansion, modernization, and sustainable future development of Traditional Chinese Medicine (TCM) in the new era;
2. Zhenjing Intelligence confirms attendance at the forum;
Hot Topics
▸ Reflections on the High-Quality Development of Traditional Chinese Medicine in the New Era
▸ Accelerated Review and Approval Processes Inject New Momentum into the Development of Traditional Chinese Medicine
▸ Dual-Directory Drive of Centralized Procurement: TCM Brand OTC Amid Consumer Recovery
▸ Innovation and Standardization Boost the Internationalization of Traditional Chinese Medicine
▸ Establishing New Consumption Standards to Reshape the Value of the Traditional Chinese Medicine Industry
▸ Deepen the “Internet + Traditional Chinese Medicine” layout to facilitate the digital and intelligent development of the traditional medicine industry
▸ Covering the entire growth cycle of young TCM practitioners to establish a closed-loop talent advancement system
▸ How Next-Generation Information Technology Comprehensively Empowers Traditional Chinese Medicine
(Agenda updates will be rolled out gradually; please stay tuned to VB100 for the latest information)
